電生理設備市場規模、佔有率、成長分析（按類型、適應症、應用、最終用戶、地區）- 2025 年至 2032 年產業預測

2023 年電生理設備市場規模價值 68 億美元，預計將從 2024 年的 74.4 億美元成長到 2032 年的 152.6 億美元，預測期內（2025-2032 年）的複合年成長率為 9.4%。

電生理學 (EP) 市場正在經歷顯著成長，這得益於心房顫動 (AF) 等心臟疾病的盛行率不斷上升以及對先進心臟監測設備的需求。造成此現象的因素包括千禧世代不健康的生活方式，美國疾病管制與預防中心預測，到2031年，約有1,210萬美國將罹患心房顫動。歐洲人尤其容易罹患心房顫動，心臟麻痹是西方國家最大的死亡原因。行動心臟監測技術的進步將進一步推動這一市場的發展，例如透過無線技術對植入設備進行遠端追蹤和數據管理，從而增強對重要患者資訊的存取。以最近 FDA 的核准為代表的微創手術和創新技術的趨勢凸顯了該領域的光明前景，因為醫療保健提供者採用 EP 設備來更好地管理心律不整。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術分析

電生理設備市場規模（按類型和複合年成長率）（2025-2032）

• 市場概覽
• 消融導管
• 診斷導管
• 地圖系統
• 配件
• 其他

電生理設備市場規模（依適應症及複合年成長率）（2025-2032）

• 市場概覽
• 心房顫動（AF）
• 房室結迴旋性心搏過速（AVNRT）
• 心室上性心搏過速
• 心搏過緩
• 沃爾夫-巴金森-懷特氏症候群（WPW）
• 其他

電生理設備市場規模（依應用和複合年成長率）（2025-2032）

• 市場概覽
• 診斷設備
  • 診斷電生理導管
  • 連續型心電圖監測裝置
  • EP 映射與成像系統
  • 心電圖（ECG）
  • 可植入心臟監視器 (ICM)
  • 其他
• 治療設備
  • 自動體外電擊器（AED）
  • 植入式心臟整流去顫器（ICD）
  • CRT-D
  • CRT-P
  • 導管
  • 心律調節器
  • 其他

電生理設備市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院
• 門診手術中心
• 其他

電生理設備市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Medtronic plc（Ireland）
• GE Healthcare（USA）
• Siemens Healthineers（Germany）
• Koninklijke Philips NV（Netherlands）
• MicroPort Scientific Corporation（China）
• Nihon Kohden Corporation（Japan）
• Stereotaxis, Inc.（USA）
• Biosense Webster, Inc.（USA）
• Biotronik SE & Co. KG（Germany）
• CardioFocus, Inc.（USA）
• CathVision ApS（Denmark）
• Japan Lifeline Co., Ltd.（Japan）
• Lepu Medical Technology（Beijing）Co., Ltd.（China）
• Osypka AG（Germany）
• Pentax Medical（Japan）
• Shanghai MicroPort EP MedTech Co., Ltd.（China）
• Teleflex Incorporated（USA）
• Topera, Inc.（USA）

結論和建議

Electrophysiology Devices Market size was valued at USD 6.8 billion in 2023 and is poised to grow from USD 7.44 billion in 2024 to USD 15.26 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).

The electrophysiology (EP) market is experiencing significant growth driven by the rising prevalence of heart diseases like atrial fibrillation (AF) and the demand for advanced cardiac monitoring equipment. Contributing factors include unhealthy lifestyle choices among millennials, with predictions from the CDC estimating approximately 12.1 million Americans affected by AF by 2031. Notably, Europeans exhibit a higher susceptibility to AF, with sudden cardiac arrest being a leading cause of death in Western nations. The market is further fueled by advancements in mobile cardiac monitoring, including remote tracking of implanted devices and data management through wireless technology, enhancing access to critical patient information. The trend towards minimally invasive procedures and innovative technologies, exemplified by recent FDA approvals, underscores the sector's promising outlook as healthcare providers adopt EP devices for better arrhythmia management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Electrophysiology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Electrophysiology Devices Market Segments Analysis

Global Electrophysiology Devices Market is segmented by Type, Indication, Application, End-user and region. Based on Type, the market is segmented into Ablation Catheters, Diagnostic Catheters, Mapping System, Accessories and Others. Based on Indication, the market is segmented into Atrial Fibrillation (AF), Atrioventricular Nodal Re-entry Tachycardia (AVNRT), Supraventricular Tachycardia, Bradycardia, Wolff-Parkinson-White Syndrome (WPW) and Others. Based on Application, the market is segmented into Diagnostic Devices and Treatment Devices. Based on End-user, the market is segmented into Hospitals, Ambulatory surgical centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Electrophysiology Devices Market

The increasing incidence of cardiac arrhythmias, particularly atrial fibrillation and ventricular tachycardia, significantly propels the electrophysiology devices market. As these heart conditions become more common, the demand for precise diagnostic and therapeutic solutions rises. Electrophysiology devices play a crucial role in managing these disorders by providing essential tools for both accurate assessment and effective treatment options. The need to address the complications associated with arrhythmias is driving innovation and investment in this market, leading to advancements in device technology and enhanced patient care. Consequently, the ongoing rise in arrhythmia cases is a key impetus behind the growth of this sector.

Restraints in the Electrophysiology Devices Market

The Electrophysiology Devices market faces significant constraints due to the high costs associated with these advanced technologies. This financial barrier can hinder their widespread adoption, particularly in areas with constrained healthcare budgets or within healthcare systems that enforce strict reimbursement policies. A considerable upfront investment is required for these devices, making them less accessible to healthcare providers in economically challenged regions. Consequently, the elevated price tag acts as a critical restraint on market growth, limiting the ability to integrate these essential tools into clinical practice, thereby impacting patient care and treatment outcomes in various healthcare settings.

Market Trends of the Electrophysiology Devices Market

The electrophysiology devices market is increasingly favoring minimally invasive procedures, driven by technological advancements and innovative device designs. These catheter-based techniques facilitate accurate diagnosis and treatment of cardiac arrhythmias with significantly improved patient outcomes, including reduced discomfort, shorter recovery periods, and lower complication rates. As healthcare providers and patients alike prioritize less invasive interventions, the demand for electrophysiology devices that support these methods is poised for substantial growth. This trend not only enhances procedural efficiency but also aligns with the broader shift towards patient-centered care in the medical field, indicating a promising future for this segment of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Electrophysiology Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Ablation Catheters
• Diagnostic Catheters
• Mapping System
• Accessories
• Others

Global Electrophysiology Devices Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Atrial Fibrillation (AF)
• Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
• Supraventricular Tachycardia
• Bradycardia
• Wolff-Parkinson-White Syndrome (WPW)
• Others

Global Electrophysiology Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostic Devices
  • Diagnostic Electrophysiology Catheters
  • Holter Monitoring Devices
  • EP Mapping & Imaging Systems
  • Electrocardiograph (ECG)
  • Insertable Cardiac Monitors (ICM)
  • Others
• Treatment Devices
  • Automated external defibrillators (AEDs)
  • Implantable Cardioverter Defibrillators (ICDs)
  • CRT-D
  • CRT-P
  • Catheters
  • Pacemakers
  • Others

Global Electrophysiology Devices Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory surgical centers
• Others

Global Electrophysiology Devices Market Size & CAGR (2025-2032)

• North America (Type, Indication, Application, End-user)
  • US
  • Canada
• Europe (Type, Indication, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stereotaxis, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosense Webster, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioFocus, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CathVision ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Japan Lifeline Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pentax Medical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai MicroPort EP MedTech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topera, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations